Taupitz J, Weigel J
University of Mannheim, Faculty of Law, Mannheim, Germany.
Public Health Genomics. 2012;15(5):263-71. doi: 10.1159/000336604. Epub 2012 Jun 20.
In order to follow population-based approaches for certain causes and risks of illnesses, more and more biobanks have been set up during the last years. Here, samples and personal data of the donors are collected and saved, whereby concrete research aims, at the time of storage of the bio-probes and the related data, are mostly undetermined. Biobanks, therefore, have the character of a collection of material and data that can be used for initially undetermined research projects. Under legal aspects the question arises whether the data subjects can consent only to an already determined use of their samples and data or can consent to a general use for research. In this article, we discuss the validity of broad consent and in how far the arising deficits in data protection need to be and can be compensated. Broad consent is, in our opinion, generally legally valid. It leads, however, to an encroachment of the ruling basic principles of data protection law. The 5-pillar concept of the German Ethics Council therefore suggests additional regulations to compensate the lacks of broad consent. While other recommendations and opinions - as far as can be seen - do only describe in vague terms the conditions for statutory regulations, the opinion of the German Ethics Council comprises very concrete statements. It, therefore, might serve as a model in the international debate on privacy and biobanks. As a result of the current debate, we identify this as a paradigm shift in data protection in biobanks.
为了追踪某些疾病病因和风险的基于人群的研究方法,在过去几年里建立了越来越多的生物样本库。在这里,捐赠者的样本和个人数据被收集并保存起来,而在生物样本和相关数据存储时,具体的研究目标大多尚未确定。因此,生物样本库具有一种材料和数据集合的性质,可用于最初未确定的研究项目。从法律角度来看,问题在于数据主体是只能同意对其样本和数据进行已确定的使用,还是可以同意用于一般的研究用途。在本文中,我们讨论广泛同意的有效性以及由此产生的数据保护方面的不足在何种程度上需要并能够得到弥补。我们认为,广泛同意一般在法律上是有效的。然而,它导致了对数据保护法的主导基本原则的侵犯。因此,德国伦理委员会的五支柱概念提出了额外的规定,以弥补广泛同意的不足。虽然其他建议和意见——据我们所知——只是模糊地描述了法定规定的条件,但德国伦理委员会的意见包含了非常具体的陈述。因此,它可能成为国际上关于隐私和生物样本库辩论的一个典范。作为当前辩论的结果,我们将此视为生物样本库数据保护方面的范式转变。